David Keeling

12.4k total citations · 2 hit papers
102 papers, 7.1k citations indexed

About

David Keeling is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Keeling has authored 102 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 37 papers in Internal Medicine and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Keeling's work include Venous Thromboembolism Diagnosis and Management (37 papers), Platelet Disorders and Treatments (26 papers) and Hemophilia Treatment and Research (24 papers). David Keeling is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (37 papers), Platelet Disorders and Treatments (26 papers) and Hemophilia Treatment and Research (24 papers). David Keeling collaborates with scholars based in United Kingdom, United States and Canada. David Keeling's co-authors include Trevor Baglin, Henry G. Watson, Robert C. Tait, Michael Makris, C. R. M. Hay, Ian Mackie, Peter W. Collins, Ri Liesner, Simon Brown and David J. Perry and has published in prestigious journals such as The Lancet, Blood and Water Research.

In The Last Decade

David Keeling

99 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines on oral anticoagulation with warfarin – fourth edition

2011 396 citations David Keeling, Trevor Baglin et al. British Journal of Haematology profile →
Guidelines on the investigation and management of antiphospholipid syndrome

2012 339 citations David Keeling, Ian Mackie et al. British Journal of Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Keeling United Kingdom	42	3.4k	1.8k	1.6k	1.2k	848	102	7.1k
Armando D’Angelo Italy	46	3.0k 0.9×	2.6k 1.4×	2.4k 1.5×	1.9k 1.5×	522 0.6×	192	9.1k
Frank W.G. Leebeek Netherlands	57	6.1k 1.8×	1.7k 0.9×	2.1k 1.3×	2.4k 2.0×	1.7k 2.1×	392	12.3k
William L. Macias United States	42	1.6k 0.5×	763 0.4×	2.6k 1.6×	1.9k 1.5×	692 0.8×	90	9.9k
Domenico Prisco Italy	52	2.0k 0.6×	2.3k 1.2×	3.1k 1.9×	1.7k 1.4×	278 0.3×	376	9.5k
Alessandro Squizzato Italy	42	1.0k 0.3×	2.5k 1.4×	2.1k 1.2×	1.2k 1.0×	442 0.5×	184	5.7k
Paolo Simioni Italy	51	5.3k 1.5×	5.8k 3.2×	3.6k 2.2×	2.2k 1.8×	1.1k 1.3×	415	12.3k
Veena Chantarangkul Italy	36	1.9k 0.5×	1.3k 0.7×	857 0.5×	1.1k 0.9×	392 0.5×	115	5.7k
Elvira Grandone Italy	41	2.7k 0.8×	1.5k 0.8×	1.6k 1.0×	901 0.7×	597 0.7×	226	6.5k
Trevor Baglin United Kingdom	59	5.3k 1.6×	6.0k 3.3×	5.1k 3.1×	2.5k 2.0×	1.2k 1.4×	223	12.6k
Jean M. Connors United States	41	1.6k 0.5×	3.5k 1.9×	2.7k 1.6×	1.7k 1.3×	530 0.6×	228	8.9k

Countries citing papers authored by David Keeling

Since Specialization

Citations

This map shows the geographic impact of David Keeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Keeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Keeling more than expected).

Fields of papers citing papers by David Keeling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Keeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Keeling. The network helps show where David Keeling may publish in the future.

Co-authorship network of co-authors of David Keeling

This figure shows the co-authorship network connecting the top 25 collaborators of David Keeling. A scholar is included among the top collaborators of David Keeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Keeling. David Keeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willan, John, Harley Katz, & David Keeling. (2019). The use of artificial neural network analysis can improve the risk‐stratification of patients presenting with suspected deep vein thrombosis. British Journal of Haematology. 185(2). 289–296. 29 indexed citations

Liesner, Ri, Pratima Chowdary, Daniel P. Hart, et al.. (2018). Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise. Haemophilia. 24(4). 611–618. 6 indexed citations

Keeling, David, Frederikus A. Klok, & Grégoire Le Gal. (2015). Controversies in venous thromboembolism — 2015. Blood Reviews. 30(1). 27–33. 8 indexed citations

Wong, Henna, et al.. (2015). Venous thromboembolism: risk of recurrence and long-term anticoagulation. British Journal of Hospital Medicine. 76(2). 72–77. 3 indexed citations

MacCallum, Peter, Louise Bowles, & David Keeling. (2014). Diagnosis and management of heritable thrombophilias. BMJ. 349(jul17 1). g4387–g4387. 37 indexed citations

Desborough, Michael & David Keeling. (2013). How to interpret a prolonged prothrombin time or activated partial thromboplastin time. British Journal of Hospital Medicine. 74(Sup1). C10–C12. 2 indexed citations

Keeling, David, Ian Mackie, Gary Moore, Ian A. Greer, & M. Greaves. (2012). Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology. 157(1). 47–58. 339 indexed citations breakdown →

Dabrera, Gavin, et al.. (2012). Is preparedness for CBRN incidents important to general practitioners in East London?. PubMed. 6(1). 47–47. 1 indexed citations

Tait, Robert C., Trevor Baglin, Henry G. Watson, et al.. (2012). Guidelines on the investigation and management of venous thrombosis at unusual sites. British Journal of Haematology. 159(1). 28–38. 112 indexed citations

10.

Berntorp, Erik, David Keeling, Michael Makris, et al.. (2011). A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use. Haemophilia. 18(4). 503–509. 11 indexed citations

11.

Sørensen, Benny, Gary Benson, Melanie Bladen, et al.. (2011). Management of muscle haematomas in patients with severe haemophilia in an evidence‐poor world. Haemophilia. 18(4). 598–606. 24 indexed citations

12.

Keeling, David, et al.. (2006). The management of heparin‐induced thrombocytopenia. British Journal of Haematology. 133(3). 259–269. 113 indexed citations

13.

Baker, Peter, et al.. (2006). Reversal of asymptomatic over‐anticoagulation by orally administered vitamin K. British Journal of Haematology. 133(3). 331–336. 21 indexed citations

14.

Bowen, D. J., Peter W. Collins, Will Lester, et al.. (2005). The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co‐segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. British Journal of Haematology. 128(6). 830–836. 18 indexed citations

15.

Darby, Stephen E., David Keeling, Rosemary J. D. Spooner, et al.. (2004). The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99. Journal of Thrombosis and Haemostasis. 2(7). 1047–1054. 211 indexed citations

16.

Keeling, David. (2003). Combined oral contraceptives and the risk of myocardial infarction. Annals of Medicine. 35(6). 413–418. 22 indexed citations

17.

Keeling, David, et al.. (2001). Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass. British Journal of Anaesthesia. 87(6). 844–847. 27 indexed citations

18.

Hay, C. R. M., Trevor Baglin, P. Collins, F. G. H. Hill, & David Keeling. (2000). The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). British Journal of Haematology. 111(1). 78–90. 108 indexed citations

19.

Keeling, David. (1999). Hormone Replacement Therapy and Venous Thromboembolism. The Journal of the British Menopause Society. 5(3). 135–136. 1 indexed citations

20.

Keeling, David, Erica M. Richards, & Trevor Baglin. (1994). Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin‐induced thrombocytopenia. British Journal of Haematology. 86(2). 425–426. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact